Compare PSNY & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSNY | OMCL |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | 2001 |
| Metric | PSNY | OMCL |
|---|---|---|
| Price | $20.64 | $47.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $47.80 |
| AVG Volume (30 Days) | 409.3K | ★ 636.3K |
| Earning Date | 09-03-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $2,547,619,000.00 | $1,177,740,000.00 |
| Revenue This Year | $49.69 | $8.61 |
| Revenue Next Year | $44.50 | $4.22 |
| P/E Ratio | ★ N/A | $110.32 |
| Revenue Growth | ★ 24.82 | 10.67 |
| 52 Week Low | $11.75 | $22.66 |
| 52 Week High | $42.60 | $47.69 |
| Indicator | PSNY | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 74.66 | 69.21 |
| Support Level | $19.50 | $44.17 |
| Resistance Level | $23.28 | $46.56 |
| Average True Range (ATR) | 1.73 | 1.34 |
| MACD | 0.36 | -0.25 |
| Stochastic Oscillator | 80.67 | 96.77 |
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.